This trial will evaluate whether a new meningitis vaccine is safe and effective in people who have previously been vaccinated against meningitis.
6 Primary · 7 Secondary · Reporting Duration: At 1 month after the vaccination schedule (i.e., Day 31 for ABCWY group [first dose] and ACWY group, Day 211 for ABCWY group [second dose]) versus Day 1
1206 Total Participants · 2 Treatment Groups
Primary Treatment: MenABCWY vaccine · Has Placebo Group · Phase 3
Age < 65 · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: